Trials / Completed
CompletedNCT02180958
Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs
Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs. Prospective, Multi-center and Observational French Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Medtronic Neurovascular Clinical Affairs · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
To assess safety and efficacy of ONYX treatment for cAVM:
Detailed description
The main objective of this study is to assess the safety at 1 month after any embolization session and the efficacy at: * 12 months post last embolization in case of treatment with embolization only * 12 months after additional treatment with neurosurgery * 36 months after additional treatment with radiosurgery
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2014-07-03
- Last updated
- 2022-01-31
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02180958. Inclusion in this directory is not an endorsement.